Alpha 2 Agonists for Sedation to Produce Better Outcomes from Critical Illness (A2B Trial): A Parallel Group Randomised Controlled Trial Comparing Clonidine, Dexmedetomidine and Current Usual Care.

Project Details

Short titleR:KAC DARP4
StatusActive
Effective start/end date1/04/18 → 30/09/23

Collaborative partners

  • The University of Manchester
  • Edinburgh Napier University (Collaborator)
  • West Hertfordshire Hospitals NHS Trust (Collaborator)
  • The University of Warwick (Collaborator)
  • Queen's University Belfast (Collaborator)
  • University College London (UCL) (Collaborator)
  • City University of London (Collaborator)
  • NHS Lothian (Collaborator)
  • University of Edinburgh (Collaborator) (lead)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint